Galera Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Galera Therapeutics

10/11/2021 13:25

* Galera Therapeutics Inc  GRTX.OQ  reported a quarterly
adjusted loss of 86 cents​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 77 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Galera Therapeutics Inc's reported EPS for the quarter was a
loss of 86 cents​.
* The mean earnings estimate of analysts had risen by
about 13.3% in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* Galera Therapeutics Inc shares had fallen by 77.5% this
quarter and lost 82.2% so far this year.
* The company reported a quarterly loss of $22.63 million.
* Wall Street's median 12-month price target for Galera
Therapeutics Inc is $16.00 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated November 10 at 01:25 p.m.
 ​All figures in US dollars unless otherwise stated